|1.||Latib, Azeem: 1 article (12/2008)|
|2.||Airoldi, Flavio: 1 article (12/2008)|
|3.||Brambilla, Nedy: 1 article (12/2008)|
|4.||Briguori, Carlo: 1 article (12/2008)|
|5.||Bonizzoni, Erminio: 1 article (12/2008)|
|6.||Bedogni, Francesco: 1 article (12/2008)|
|7.||Chieffo, Alaide: 1 article (12/2008)|
|8.||Montorfano, Matteo: 1 article (12/2008)|
|9.||Cosgrave, John: 1 article (12/2008)|
|10.||Godino, Cosmo: 1 article (12/2008)|
01/01/1987 - "Between July 1, 1981, and July 1, 1985, 167 patients with acute myelogeneous leukemia (AML) were treated with one or, if necessary, two courses of a modified TAD regimen (TAD9) for induction. "
06/01/1985 - "102 patients with AML (leukemia after preleukemia, 2nd neoplasia included) were treated for remission induction by a modified TAD regimen in Munster; 55 patients (54%) achieved a complete remission (CR). "
|3.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/01/1987 - "Ninety-seven patients less than or equal to 70 years of age with previously untreated primary acute myeloblastic leukemia were randomly treated with either the DAT or TAD regimen: daunorubicin (70 mg/m2/day) administered on Days 1-3 (DAT) or 5-7 (TAD) of a 7-day sequence consisting of cytarabine (200 mg/m2/day) and 6-thioguanine (200 mg/m2/day). "
11/01/1993 - "These results suggest that in DAT: (i) significant brain atrophy is present early in the disease process, (ii) brain atrophy correlates with severity of cognitive impairment, and (iii) there is greater involvement of the telencephalic association system than whole brain, and there is relative sparing of the caudate, lenticular and thalamic nuclei."
|4.||Aspirin (Acetylsalicylic Acid)